The present invention provides novel compounds and methods useful for
treating transglutaminase associated disorders such as celiac spru,
Alzheimer's disease and Huntington's disease. Certain compounds of the
invention are tissue transglutaminase inhibitors that comprise thiophene
moieties. Methods of the invention include treatment of transglutaminase
associated disorders with inhibitors of transglutaminase.